Schoenfeld AJ, Losina E, Ferrone ML, et al. - Among patients (40 to 80 years old) treated for spinal metastases between 2005 and 2017, researchers investigated how the maintenance of ambulatory function and survival were influenced by operative vs nonoperative treatment. The participants were independent ambulators at presentation and had fewer than five medical comorbidities. Of 929 eligible individuals selected, 402 were retained following propensity score matching, including 201 operative patients and 201 nonoperative patients. Findings revealed that the likelihood to lose ambulatory function 6 months following presentation was lower among patients treated operatively vs those managed nonoperatively in a group of patients with similar demographic and clinical features.